Oramed Pharmaeuticals, a developer of oral drug delivery systems, has appointed Joshua Hexter as chief operating officer and vice president of business development.

Hexter brings to Oramed more than 15 years of prominent leadership with a commitment to excellence in the biotech industry in business development and operations. Most recently he served as executive director of corporate in-licensing at BioLineRx.